霍奇金淋巴瘤（霍奇金病）

预约门诊

生存率

对于大多数霍奇金淋巴瘤患者，存活概率相当乐观。为了解淋巴瘤的生存率，专家会研究大量淋巴瘤患者，观察他们在确诊后 5 年内的存活人数。

对于 1 期霍奇金淋巴瘤，患者确诊后至少存活 5 年的概率为 92%。随着癌症扩散，存活概率会降低。对于 4 期霍奇金淋巴瘤，患者确诊后至少存活 5 年的概率约为 82%。

需注意生存统计数据需要 5 年时间采集。最新的生存率数据包含 5 年前接受过淋巴瘤治疗的患者。这些患者可能未接触过最新疗法。在过去数十年间，淋巴瘤的死亡率持续下降，生存率稳步提升。

申请预约
分期医生与科室
Sept. 24, 2025

Living with 霍奇金淋巴瘤（霍奇金病）?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

patientk
Anybody else have Factor V Leiden?

65 Replies Tue, Jan 13, 2026

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

815 Replies Sun, Jan 11, 2026

See more discussions
  1. Hodgkin lymphoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1439. Accessed Aug. 19, 2025.
  2. Hodgkin lymphoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq. Accessed Aug. 19, 2025.
  3. Elsevier Point of Care. Clinical Overview: Hodgkin lymphoma. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  4. Cancer stat facts: Hodgkin lymphoma. National Cancer Institute. https://seer.cancer.gov/statfacts/html/hodg.html. Accessed Aug. 19, 2025.
  5. Hoffman R, et al. Hodgkin lymphoma. In: Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  6. Ferri FF. Hodgkin lymphoma. In: Ferri's Clinical Advisor 2026. Elsevier; 2026. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  7. Ng AK, et al. Classic Hodgkin lymphoma: Presentation, evaluation, and diagnosis in adults. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  8. LaCasce AS, et al. Pretreatment evaluation, staging, and treatment stratification of classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  9. LaCasce AS. Treatment of relapsed or refractory classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  10. Chemotherapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy#chemotherapy-can-cause-side-effects. Accessed Aug. 19, 2025.
  11. Radiation therapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects. Accessed Aug. 19, 2025.
  12. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology. 2017; doi:10.1200/JCO.2016.71.2083.
  13. Goyal G, et al. Association between facility volume and mortality of patients with classic Hodgkin lymphoma. Cancer. 2019; doi:10.1002/cncr.32584.
  14. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Aug. 19, 2025.
  15. Membership institution lists. NRG Oncology. https://www.nrgoncology.org/About-Us/Membership/Member-Institution-Lists. Accessed Aug. 19, 2025.
  16. Stem cell transplants in cancer treatments. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant#stem-cell-transplant-side-effects. Accessed Aug. 19, 2025.
  17. Elsevier Point of Care. Clinical Overview: Febrile neutropenia in adults. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  18. Immunotherapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects. Accessed Aug. 19, 2025.
  19. Targeted therapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed Aug. 19, 2025.

相关

相关医疗程序

Mayo Clinic 新闻

产品与服务

霍奇金淋巴瘤（霍奇金病）